Secukinumab

Secukinumab is a medication that helps manage certain autoimmune conditions, such as psoriasis and psoriatic arthritis. It works by targeting a specific protein called interleukin-17A, which plays a role in promoting inflammation and overactive immune responses. By blocking this protein, secukinumab reduces inflammation, leading to clearer skin and improved joint function. It is administered via injections, typically given once a month after initial doses. Secukinumab is prescribed by a healthcare provider and helps improve quality of life for people with these chronic inflammatory conditions.